ZA956209B - Azaaliphatically bridged quinoxaline-2,3-diones - Google Patents
Azaaliphatically bridged quinoxaline-2,3-dionesInfo
- Publication number
- ZA956209B ZA956209B ZA956209A ZA956209A ZA956209B ZA 956209 B ZA956209 B ZA 956209B ZA 956209 A ZA956209 A ZA 956209A ZA 956209 A ZA956209 A ZA 956209A ZA 956209 B ZA956209 B ZA 956209B
- Authority
- ZA
- South Africa
- Prior art keywords
- azaaliphatically
- diones
- bridged quinoxaline
- quinoxaline
- bridged
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH236694 | 1994-07-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA956209B true ZA956209B (en) | 1996-01-29 |
Family
ID=4232111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA956209A ZA956209B (en) | 1994-07-27 | 1995-07-26 | Azaaliphatically bridged quinoxaline-2,3-diones |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0705834A1 (en) |
| JP (1) | JPH0873465A (en) |
| KR (1) | KR960004346A (en) |
| CN (1) | CN1117493A (en) |
| AU (1) | AU2711695A (en) |
| BR (1) | BR9503458A (en) |
| CA (1) | CA2154624A1 (en) |
| FI (1) | FI953549A (en) |
| HU (1) | HUT73438A (en) |
| IL (1) | IL114729A0 (en) |
| NO (1) | NO952959L (en) |
| NZ (1) | NZ272639A (en) |
| ZA (1) | ZA956209B (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063774A (en) * | 1996-12-16 | 2000-05-16 | Warner-Lambert Company | Tricyclic quinoxaline derivatives as neuroprotective agents |
| BR9814628A (en) | 1997-11-11 | 2001-11-27 | Ono Pharmaceutical Co | Fused pyrazine derivatives |
| EP2493905B1 (en) | 2009-10-26 | 2016-11-30 | Warner Chilcott Company, LLC | Bisphosphonate compounds for treating bone metabolism disorders |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK715888D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
| DK716188D0 (en) * | 1988-12-22 | 1988-12-22 | Ferrosan As | QUINOXAL COMPOUNDS, THEIR PREPARATION AND USE |
| DE69016430T2 (en) * | 1989-06-09 | 1995-06-01 | Upjohn Co | HETEROCYCLIC AMINES WITH CNS EFFECTIVENESS. |
| JPH05117276A (en) * | 1991-10-23 | 1993-05-14 | Sumitomo Pharmaceut Co Ltd | New tricyclic quinoxalinedione derivative |
| EP0647137B1 (en) * | 1992-06-22 | 2008-08-13 | The Regents Of The University Of California | Glycine receptor antagonists and the use thereof |
| EP0664807B1 (en) * | 1992-10-13 | 1997-09-10 | Warner-Lambert Company | Quinoxalinedione derivatives as eaa antagonists |
| US5631373A (en) * | 1993-11-05 | 1997-05-20 | State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon | Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
-
1995
- 1995-07-18 EP EP95810470A patent/EP0705834A1/en not_active Withdrawn
- 1995-07-20 AU AU27116/95A patent/AU2711695A/en not_active Abandoned
- 1995-07-24 FI FI953549A patent/FI953549A/en not_active Application Discontinuation
- 1995-07-25 IL IL11472995A patent/IL114729A0/en unknown
- 1995-07-25 JP JP7189177A patent/JPH0873465A/en active Pending
- 1995-07-25 NZ NZ272639A patent/NZ272639A/en unknown
- 1995-07-25 CA CA002154624A patent/CA2154624A1/en not_active Abandoned
- 1995-07-26 CN CN95108718A patent/CN1117493A/en active Pending
- 1995-07-26 BR BR9503458A patent/BR9503458A/en not_active Application Discontinuation
- 1995-07-26 NO NO952959A patent/NO952959L/en unknown
- 1995-07-26 KR KR1019950022224A patent/KR960004346A/en not_active Application Discontinuation
- 1995-07-26 HU HU9502240A patent/HUT73438A/en unknown
- 1995-07-26 ZA ZA956209A patent/ZA956209B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ272639A (en) | 1997-05-26 |
| FI953549A (en) | 1996-01-28 |
| JPH0873465A (en) | 1996-03-19 |
| IL114729A0 (en) | 1995-11-27 |
| BR9503458A (en) | 1996-02-27 |
| NO952959L (en) | 1996-01-29 |
| HU9502240D0 (en) | 1995-09-28 |
| CA2154624A1 (en) | 1996-01-28 |
| KR960004346A (en) | 1996-02-23 |
| AU2711695A (en) | 1996-02-08 |
| CN1117493A (en) | 1996-02-28 |
| NO952959D0 (en) | 1995-07-26 |
| EP0705834A1 (en) | 1996-04-10 |
| HUT73438A (en) | 1996-07-29 |
| FI953549A0 (en) | 1995-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9711092B (en) | Novel compounds. | |
| EP0676786A3 (en) | Compact protector. | |
| DE59812367D1 (en) | 2-arylcyclopentan-1,3-dione | |
| PL328505A1 (en) | 2-heteroaroylcyclohexano-1,3-diones | |
| DE69723848D1 (en) | 3-descladinose-2,3-anhydroerythromycin-derivate | |
| ZA975280B (en) | Filter. | |
| ZA9711567B (en) | Compounds. | |
| ZA987056B (en) | 2-benzoylcyclohexane-1,3-diones. | |
| IL115103A0 (en) | Oxa - or thia-aliphatically bridged quinoxaline - 2,3-diones | |
| ZA975861B (en) | Bromotiacumicin compounds. | |
| ZA971676B (en) | Filter. | |
| ZA97928B (en) | Novel heteroaryl-oxazolidinones. | |
| PL334473A1 (en) | Substituted 2-benzoylcyclohexano-1,3-diones | |
| EP0684299A3 (en) | Dihydrofarnesal. | |
| ZA974052B (en) | New benzothiazolinones. | |
| ZA956209B (en) | Azaaliphatically bridged quinoxaline-2,3-diones | |
| GR3034943T3 (en) | Medrogestrone. | |
| EP0672364A3 (en) | Skiboot. | |
| ZA974056B (en) | New thiazolopyridines. | |
| EP0671133A3 (en) | Skiboot. | |
| ZA979404B (en) | Aspirinate compounds. | |
| ZA957307B (en) | Oxa- or thia-aliphatically bridged quinoxaline-2,3-diones | |
| PL336794A1 (en) | Substituted 2-benzoylcyclohexane-1,3-diones | |
| ZA971503B (en) | 2-hetaroylcyclohexane-1,3-diones | |
| ZA97415B (en) | Novel compounds. |